| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 125.74B | 133.13B | 134.60B | 123.67B | 124.49B |
| Gross Profit | 55.18B | 67.02B | 69.57B | 59.74B | 60.18B |
| EBITDA | 17.80B | 35.95B | 36.53B | 30.70B | 27.12B |
| Net Income | 5.44B | 23.76B | 20.32B | 7.56B | 10.23B |
Balance Sheet | |||||
| Total Assets | 449.35B | 427.78B | 406.76B | 390.97B | 380.03B |
| Cash, Cash Equivalents and Short-Term Investments | 115.54B | 127.44B | 193.90B | 174.00B | 180.09B |
| Total Debt | 101.23B | 79.32B | 84.59B | 91.35B | 91.51B |
| Total Liabilities | 159.50B | 144.17B | 144.15B | 153.17B | 156.08B |
| Stockholders Equity | 266.44B | 263.62B | 243.63B | 223.48B | 211.46B |
Cash Flow | |||||
| Free Cash Flow | -14.70B | 13.10B | 25.32B | 17.78B | 8.88B |
| Operating Cash Flow | -2.94B | 21.23B | 36.62B | 26.17B | 20.12B |
| Investing Cash Flow | -22.18B | -8.55B | -50.40B | -3.94B | -31.44B |
| Financing Cash Flow | 14.39B | -13.76B | -14.16B | -6.39B | 23.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$203.92B | 13.56 | 25.44% | ― | 11.37% | 16.74% | |
73 Outperform | HK$105.25B | 17.65 | 13.77% | 1.01% | 13.62% | 80.52% | |
67 Neutral | HK$28.05B | -39.92 | -4.08% | ― | -10.26% | -85.75% | |
65 Neutral | HK$4.59T | 22.32 | 20.51% | 0.75% | 13.15% | 30.78% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | HK$17.22B | 5.39 | 12.13% | 8.13% | -1.40% | 22.37% | |
53 Neutral | HK$294.46B | 59.14 | 2.02% | ― | -2.92% | -57.12% |